CV Sciences (CVSI) Treasury Shares (2014 - 2022)
CV Sciences (CVSI) reported Treasury Shares of $6.8 million for Q4 2022, up 30.27% on a YoY basis from $5.2 million in Q4 2021, and up 30.27% sequentially from $5.2 million in Q4 2021.
CV Sciences (CVSI) Treasury Shares (2014 - 2022) Analysis & Trends
CV Sciences (CVSI) has 9 years of Treasury Shares data on file, last reported at $6.8 million in Q4 2022.
- For the quarter ending Q4 2022, Treasury Shares rose 30.27% year-over-year to $6.8 million; the trailing twelve-month figure through Dec 2022 stood at $6.8 million (up 30.27% YoY), and the FY2022 full-year result was $6.8 million, up 30.27% from the prior year.
- Treasury Shares climbed to $6.8 million in Q4 2022, from $5.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $8.9 million in Q4 2019 to a low of $2.5 million in Q1 2018.
- A 5-year average of $4.9 million and a median of $4.3 million in 2018 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares sank 67.85% in 2018 and surged 200.44% in 2019, its largest moves.
- Tracing CVSI's Treasury Shares over 5 years: stood at $2.9 million in 2018, then surged by 200.44% to $8.9 million in 2019, then plunged by 30.44% to $6.2 million in 2020, then slipped by 15.23% to $5.2 million in 2021, then soared by 30.27% to $6.8 million in 2022.
- Business Quant data shows CVSI's Treasury Shares at $6.8 million in Q4 2022, $5.2 million in Q4 2021, and $6.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 6.81 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Dec 31, 2021 | 5.23 Mn |
| Dec 31, 2021 | 5.23 Mn |
| Dec 31, 2020 | 6.17 Mn |
| Dec 31, 2020 | 6.17 Mn |
| Dec 31, 2019 | 8.86 Mn |
| Dec 31, 2019 | 8.86 Mn |
| Dec 31, 2018 | 2.95 Mn |
| Dec 31, 2018 | 2.95 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Jun 30, 2018 | 3.35 Mn |
| Jun 30, 2018 | 3.35 Mn |
| Mar 31, 2018 | 2.51 Mn |
| Mar 31, 2018 | 2.51 Mn |
| Dec 31, 2017 | 9.18 Mn |
| Dec 31, 2017 | 9.18 Mn |
| Sep 30, 2017 | 9.33 Mn |
| Sep 30, 2017 | 9.33 Mn |